Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jul;18(1):182–189. doi: 10.1128/aac.18.1.182

Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.

A R White, K R Comber, R Sutherland
PMCID: PMC283961  PMID: 6774663

Abstract

Azlocillin was relatively ineffective against actively growing cultures of Pseudomonas aeruginosa in tests of bacteriolytic and bactericidal activity in which ticarcillin demonstrated pronounced bactericidal effects over a wide range of concentrations. Microscopic observation showed that azlocillin generally induced the formation of filamentous cells of P. aeruginosa which lysed only slowly, but ticarcillin caused the production of spheroplasts and subsequent rapid lysis. During the course of the bactericidal tests, azlocillin was inactivated, presumably by the beta-lactamase produced by P. aeruginosa, and the filamentous cells resumed normal cell division and growth. In contrast, there was no loss of ticarcillin activity, and there was no evidence of resumption of growth of P. aeruginosa in the presence of ticarcillin. These results suggest that the different bactericidal effects demonstrated by azlocillin and ticarcillin against P. aeruginosa are related primarily to dose-related differences in inhibition of cell wall synthesis and secondarily to the instability of azlocillin to pseudomonal beta-lactamase.

Full text

PDF
182

Images in this article

186Image
on p.186
187Image
on p.187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basker M. J., Edmondson R. A., Sutherland R. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes. Infection. 1979;7(2):67–73. doi: 10.1007/BF01641616. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin. Antimicrob Agents Chemother. 1977 Jan;11(1):74–79. doi: 10.1128/aac.11.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodey G. P., Weaver S., Pan T. PC-904, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1978 Jan;13(1):14–18. doi: 10.1128/aac.13.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coppens L., Klastersky J. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin. Antimicrob Agents Chemother. 1979 Mar;15(3):396–399. doi: 10.1128/aac.15.3.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fu K. P., Neu H. C. Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother. 1978 Jun;13(6):930–938. doi: 10.1128/aac.13.6.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fu K. P., Neu H. C. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358–367. doi: 10.1128/aac.13.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. König H. B., Metzger K. G., Mürmann R. P., Offe H. A., Schacht P., Schröck W. Azlocillin-ein neues Penicillin gegen Pseudomonas aeruginosa und andere gramnegative Bakterien. Infection. 1977;5(3):170–182. doi: 10.1007/BF01639754. [DOI] [PubMed] [Google Scholar]
  8. Noguchi H., Eda Y., Tobiki H., Nakagome T., Komatsu T. PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation. Antimicrob Agents Chemother. 1976 Feb;9(2):262–273. doi: 10.1128/aac.9.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Noguchi H., Kubo M., Kurashige S., Mitsuhashi S. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates. Antimicrob Agents Chemother. 1978 May;13(5):745–752. doi: 10.1128/aac.13.5.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rolinson G. N., Sutherland R. Semisynthetic penicillins. Adv Pharmacol Chemother. 1973;11:151–220. doi: 10.1016/s1054-3589(08)60458-5. [DOI] [PubMed] [Google Scholar]
  11. Sanders C. C., Sanders W. E., Jr BL-P1654: a bacteriostatic penicillin? Antimicrob Agents Chemother. 1975 Apr;7(4):435–440. doi: 10.1128/aac.7.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shah P. P., Briedis D. J., Robson H. G., Conterato J. P. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother. 1979 Mar;15(3):346–350. doi: 10.1128/aac.15.3.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stewart D., Bodey G. P. Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 May;11(5):865–870. doi: 10.1128/aac.11.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ueo K., Fukuoka Y., Hayashi T., Yasuda T., Taki H., Tai M., Watanabe Y., Saikawa I., Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 Oct;12(4):455–460. doi: 10.1128/aac.12.4.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES